Article info
PDFOriginal research
Does timing matter on tocilizumab administration? Clinical, analytical and radiological outcomes in COVID-19
- Correspondence to Raquel Moreno Diaz, Pharmacy, Hospital Universitario Infanta Cristina, 28981 Parla, Spain; rmorenod{at}salud.madrid.org
Citation
Does timing matter on tocilizumab administration? Clinical, analytical and radiological outcomes in COVID-19
Publication history
- Received December 23, 2020
- Revised January 29, 2021
- Accepted February 2, 2021
- First published February 24, 2021.
Article Versions
- Previous version (24 February 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© European Association of Hospital Pharmacists 2021. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage